← back to search

Peixun Wang

Guangzhou University of Chinese Medicine · CN
Area of research
Pharmacology · Ceramics and Composites
Research interest
Research interests include Sinomenine, Pharmacology, Tumor necrosis factor alpha, Inflammation, MAPK/ERK pathway, and Chemistry.
h-index
citations
504
works
14
NIH funding
primary concept
email

Recent publications

Sinomenine regulates the cholinergic anti-inflammatory pathway to inhibit TLR4/NF-κB pathway and protect the homeostasis in brain and gut in scopolamine-induced Alzheimer’s disease mice
Biomedicine & Pharmacotherapy 2024cited by 37position: middledoi
Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways
Acta Pharmacologica Sinica 2023cited by 52position: middledoi
Sinomenine inhibits macrophage M1 polarization by downregulating α7nAChR via a feedback pathway of α7nAChR/ERK/Egr-1
Phytomedicine 2022cited by 31position: middledoi
Inhibitory effect of sinomenine on lung cancer cells via negative regulation of α7 nicotinic acetylcholine receptor
Journal of Leukocyte Biology 2020cited by 28position: middledoi
Sinomenine regulates CD14/TLR4, JAK2/STAT3 pathway and calcium signal via α7nAChR to inhibit inflammation in LPS-stimulated macrophages
Immunopharmacology and Immunotoxicology 2019cited by 51position: middledoi
Alpha7 nAChR Expression Is Correlated with Arthritis Development and Inhibited by Sinomenine in Adjuvant-Induced Arthritic Rats
Evidence-based Complementary and Alternative Medicine 2019cited by 22position: middledoi
Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway
International Immunopharmacology 2018cited by 46position: middledoi
Corrigendum to “Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway” [Int. Immunopharmacol. 56 (2018) 65–70]
International Immunopharmacology 2018cited by 1position: middledoi
Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis
Biochemical Pharmacology 2017cited by 65position: middledoi
Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-κB signaling
Pharmacological Research 2017cited by 28position: middledoi
Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling
Pharmacological Research 2016cited by 60position: middledoi
α7 Nicotinic Acetylcholine Receptor is a Novel Mediator of Sinomenine Anti-Inflammation Effect in Macrophages Stimulated by Lipopolysaccharide
Shock 2015cited by 55position: middledoi
Rabbit Sera Containing Compound Danshen Dripping Pill Attenuate Leukocytes Adhesion to TNF-Alpha–Activated Human Umbilical Vein Endothelial Cells by Suppressing Endothelial ICAM-1 and VCAM-1 Expression Through NF-KappaB Signaling Pathway
Journal of Cardiovascular Pharmacology 2013cited by 28position: middledoi
Comparison of RBL-2H3 Cell and Primary Mast Cell Degranulation Induced by Xuesaitong Injection
Guangzhou Zhongyiyao Daxue xuebao 2012cited by 0position: first

Grants

No grants ingested yet.

Frequent collaborators

Hua Zhou · Guangzhou University of Chinese Medicine12 papers (2015–2024)Yan Dong · Guangzhou University of Chinese Medicine8 papers (2015–2024)Liang Liu · Hebei Medical University8 papers (2015–2022)Lang Yi · Guangzhou University of Chinese Medicine8 papers (2015–2024)Shasha Bai · Guangzhou University of Chinese Medicine6 papers (2018–2022)Jin-Fang Luo · Guangzhou University of Chinese Medicine4 papers (2015–2022)Yan Dong · Guangzhou University of Chinese Medicine4 papers (2016–2019)Ruili Zhu · Guangzhou University of Chinese Medicine4 papers (2018–2022)Chong Peng · Guangzhou University of Chinese Medicine3 papers (2018–2019)Yingkun Zhi · Guangzhou University of Chinese Medicine3 papers (2019–2022)Jing Li · Guangzhou University of Chinese Medicine3 papers (2019–2022)Jianxin Liu · Central South University3 papers (2015–2017)Yanjun Lv · Guangzhou University of Chinese Medicine2 papers (2019–2020)Qing-ping Shi · Guangzhou University of Chinese Medicine2 papers (2019–2022)Yi-Han Zuo · Roswell Park Comprehensive Cancer Center2 papers (2016–2017)Zhongqiu Liu · Guangzhou University of Chinese Medicine2 papers (2017–2023)Pei Luo · Ministry of Education of the People's Republic of China2 papers (2016–2017)Ying Xie · Hebei Medical University2 papers (2017–2023)Yanwu Li · Guangzhou University of Chinese Medicine2 papers (2022–2024)Qun Du · Guangzhou University of Chinese Medicine2 papers (2022–2024)